StockData
OptimizeRx Corp logo

OptimizeRx Corp (OPRX) stock

OPRXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 10/3026% below fair value
$7.31+0.37 (+5.33%)

Close on Nov 18, 2026Market cap $137.69MP/E 30.5Yield –

OptimizeRx shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

OptimizeRx's shares outstanding was 19M at Jun 30, 2026. For fiscal 2025 it was 19M, up 3.9% from the year before. Over ten years it grew 8.8% a year on average. The highest annual figure on record is 19M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202519M+3.9%
FY2024Dec 31, 202418M+6.8%
FY2023Dec 31, 202317M-3.7%
FY2022Dec 31, 202218M+0.5%
FY2021Dec 31, 202118M+19.3%
FY2020Dec 31, 202015M+10.8%
FY2019Dec 31, 201913M+12.9%
FY2018Dec 31, 201812M+20.8%
FY2017Dec 31, 201710M-0.8%
FY2016Dec 31, 201610M+20.9%
FY2015Dec 31, 20158M+2.3%
FY2014Dec 31, 20148M+13.3%
FY2013Dec 31, 20137M+23.2%
FY2012Dec 31, 20126M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 202619M-1.2%
Q1 FY2026Mar 31, 202619M+1.6%
Q4 FY2025Dec 31, 202519M+2.8%
Q3 FY2025Sep 30, 202519M+6.2%
Q2 FY2025Jun 30, 202519M+4.1%
Q1 FY2025Mar 31, 202518M+1.7%
Q4 FY2024Dec 31, 202418M+3.6%
Q3 FY2024Sep 30, 202418M+10.1%
Q2 FY2024Jun 30, 202418M+7.4%
Q1 FY2024Mar 31, 202418M+6.3%
Q4 FY2023Dec 31, 202318M+3.6%
Q3 FY2023Sep 30, 202317M-6.9%
Q2 FY2023Jun 30, 202317M-13.6%
Q1 FY2023Mar 31, 202317M-6.1%
Q4 FY2022Dec 31, 202217M-5.3%
Q1 FY2022Mar 31, 202218M+11.0%
Q4 FY2021Dec 31, 202120M+30.0%
Q3 FY2021Sep 30, 202118M+22.1%
Q2 FY2021Jun 30, 202118M+23.4%
Q1 FY2021Mar 31, 202116M+10.2%
Q4 FY2020Dec 31, 202015M+9.6%
Q3 FY2020Sep 30, 202015M+13.9%
Q2 FY2020Jun 30, 202015M+20.7%
Q1 FY2020Mar 31, 202015M+13.1%
Q2 FY2019Jun 30, 201914M+15.5%
Q1 FY2019Mar 31, 201913M+33.6%
Q4 FY2018Dec 31, 201812M+24.5%
Q3 FY2018Sep 30, 201813M+32.5%
Q2 FY2018Jun 30, 201812M+21.2%
Q1 FY2018Mar 31, 201810M-1.2%
Q4 FY2017Dec 31, 201710M-4.6%
Q3 FY2017Sep 30, 201710M-0.6%
Q2 FY2017Jun 30, 201710M+1.5%
Q1 FY2017Mar 31, 201710M+2.4%
Q4 FY2016Dec 31, 201610M–
Q3 FY2016Sep 30, 201610M–
Q2 FY2016Jun 30, 201610M–
Q1 FY2016Mar 31, 201610M–

More OptimizeRx figures

See a number that looks wrong?